Nada Hammad

61PUBLICATIONS
350CO-AUTHORS
Predictive and prognostic markersTransplantation immunologyImmunogenetics (incl. genetic immunology)Geospatial information systems and geospatial data modellingRheumatology and arthritis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (61)

|Aug 27, 2026
LTB-TREAT: A validated international prognostic model for time to treatment in low tumour burden follicular lymphoma.

|Aug 21, 2026
A randomized pilot trial comparing anti-thymocyte globulin with anti-thymocyte globulin plus post transplant cyclophosphamide for prophylaxis against acute and chronic graft versus host disease in matched donor hematopoietic cell transplants - a study from the Cell Therapy Transplant Canada/ Australasian Leukemia Lymphoma Group Consortium.

|Apr 14, 2026
Historical outcomes for patients with stage IA NLPHL: Global NLPHL One Working Group retrospective analyses.

Jamie E Flerlage, Dennis A Eichenauer, Michael Fuchs

|Feb 14, 2026
Total Body Irradiation in Australia and New Zealand: A 2024 Practice Survey on Changing Patterns of Care.

Sarah Li, Nada Hamad, Trieumy Tran Le

|Jun 25, 2025
Ruxolitinib in Patients With Corticosteroid-Refractory or Corticosteroid-Dependent Chronic Graft-Versus-Host Disease: 3-Year Final Analysis of the Phase III REACH3 Study.

Robert Zeiser, Domenico Russo, Ron Ram

|Jun 18, 2025
Glofitamab Combined With Pola-R-CHP or R-CHOP as First Therapy in Younger Patients With High-Risk Large B-Cell Lymphoma: Results From the COALITION Study.

Adrian Minson, Emma Verner, Pratyush Giri

Pageof 11

Frequent Collaborators

14 joint publications

Chan Yoon Cheah

12 joint publications

Matthew Ku

11 joint publications

Pietro R Di Ciaccio

9 joint publications

Michael J Dickinson